{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:24Z","timestamp":1793047164783,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W029235\/1"],"award-info":[{"award-number":["MR\/W029235\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019544","name":"University of Cambridge Cambridge Centre for Parkinson-Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015659","name":"Cure Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.028","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:44:08Z","timestamp":1745376248000},"page":"558-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Peripheral-central immune crosstalk in Parkinson\u2019s disease and its association with clinical severity"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-0586","authenticated-orcid":false,"given":"Julia C.","family":"Greenland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakmini","family":"Kahanawita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D.","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young T.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline H.","family":"Williams-Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"\u00c1lvarez-Luqu\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.04.028_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2703518","article-title":"Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis","volume":"2018","author":"Angkananard","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.028_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13854048908403285","article-title":"Predicting premorbid IQ: A revision of the national adult reading test","volume":"3","author":"Blair","year":"1989","journal-title":"Clinical Neuropsychologist"},{"key":"10.1016\/j.bbi.2025.04.028_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110668","article-title":"Impact of sex on neuroimmune contributions to Parkinson's disease","volume":"199","author":"Bourque","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0025","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.028_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","article-title":"The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson\u2019s disease","volume":"166","author":"Broussolle","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41531-021-00180-z","article-title":"Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease","volume":"7","author":"Carlisle","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0040","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.4049\/jimmunol.1401805","article-title":"Role and regulation of CD1d in normal and pathological B cells","volume":"193","author":"Chaudhry","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0045","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","article-title":"Clinical correlation of peripheral CD4+\u2011cell sub\u2011sets, their imbalance and Parkinson's disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"34","key":"10.1016\/j.bbi.2025.04.028_b0050","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer","volume":"23","author":"Chen","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.028_b0055","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1007\/s00415-023-11635-z","article-title":"Relationship between [(123)I]FP-CIT SPECT data and peripheral CD4\u2009+\u2009T cell profile in newly-diagnosed drug-na\u00efve Parkinson's disease patients","volume":"270","author":"Contaldi","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2025.04.028_b0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JPD-212914","article-title":"Peripheral immune cell numbers and C-reactive protein in Parkinson\u2019s disease: results from a population-based study","volume":"12","author":"Dommershuijsen","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbi.2025.04.028_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00332","article-title":"Predictive value of routine peripheral blood biomarkers in Alzheimer\u2019s disease","volume":"11","author":"Dong","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.028_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu103","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease","volume":"18","author":"Drouin-Ouellet","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41581-023-00787-w","article-title":"Mechanisms and consequences of sex differences in immune responses","volume":"20","author":"Dunn","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.028_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology","volume":"133","author":"Dzamko","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.028_b0085","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13037","article-title":"Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis","volume":"49","author":"Erre","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbi.2025.04.028_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1432342","article-title":"Inflammation and heterogeneity in synucleinopathies","volume":"15","author":"Freuchet","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.028_b0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.25300","article-title":"Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease","volume":"28","author":"Funk","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan","year":"2019","journal-title":"Ann. Lab. Med."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.028_b0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"15","key":"10.1016\/j.bbi.2025.04.028_b0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.028_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040527","article-title":"Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol","volume":"10","author":"Greenland","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbi.2025.04.028_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.028_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson's disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","article-title":"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","volume":"19","author":"Hammers","year":"2003","journal-title":"Hum. Brain Mapp."},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0145","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","article-title":"Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease","volume":"269","author":"He","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2025.04.028_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578154","article-title":"Natural killer cells have an activated profile in early Parkinson's disease","volume":"382","author":"Holbrook","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"3\u20134","key":"10.1016\/j.bbi.2025.04.028_b0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000351671","article-title":"Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease","volume":"36","author":"Hsieh","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"23","key":"10.1016\/j.bbi.2025.04.028_b0160","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.028_b0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2025.04.028_b0170","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp-2023-331170","article-title":"Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson's disease","volume":"94","author":"Jeong","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.028_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","article-title":"CD57 in human natural killer cells and T-lymphocytes","volume":"65","author":"Kared","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbi.2025.04.028_b0185","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2025.04.028_b0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2022.01.005","article-title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition","volume":"101","author":"Konstantin Nissen","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.028_b0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nn.4610","article-title":"High-dimensional, single-cell characterization of the brain's immune compartment","volume":"20","author":"Korin","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson's disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12974-021-02287-9","article-title":"T lymphocyte senescence is attenuated in Parkinson's disease","volume":"18","author":"Kouli","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bbi.2025.04.028_b0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/awad322","article-title":"Neuroinflammation is linked to dementia risk in Parkinson's disease","volume":"147","author":"Kouli","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2025.04.028_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0230","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"92","author":"Lagunas-Rangel","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/eji.202149318","article-title":"Helios is a marker, not a driver, of human Treg stability","volume":"52","author":"Lam","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"3 Pt 1","key":"10.1016\/j.bbi.2025.04.028_b0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbi.2025.04.028_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [(18)F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbi.2025.04.028_b0250","article-title":"Serum folate, vitamin B12 levels, and systemic immune-inflammation index correlate with motor performance in Parkinson's disease: a cross-sectional study","volume":"12","author":"Li","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","article-title":"Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13293-022-00477-5","article-title":"Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies","volume":"13","author":"L\u00f3pez-Cerd\u00e1n","year":"2022","journal-title":"Biol. Sex Differ."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.028_b0265","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"s1","key":"10.1016\/j.bbi.2025.04.028_b0270","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.3233\/JPD-223212","article-title":"New insights and implications of natural killer cells in Parkinson's disease","volume":"12","author":"Menees","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0275","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/mds.28685","article-title":"Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson's disease","volume":"36","author":"Mu\u00f1oz-Delgado","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2025.04.028_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.028_b0285","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.27815","article-title":"Alterations in blood monocyte functions in Parkinson's disease","volume":"34","author":"Nissen","year":"2019","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mds.28424","article-title":"Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson's disease","volume":"36","author":"Nissen","year":"2021","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.028_b0295","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2025.04.028_b0300","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jcpa.2009.09.005","article-title":"Senescence of the human immune system","volume":"142","author":"Pawelec","year":"2010","journal-title":"J. Comp. Pathol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10072-018-3592-y","article-title":"Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients","volume":"40","author":"Ping","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbi.2025.04.028_b0310","doi-asserted-by":"crossref","unstructured":"Ribeiro, J., et al., 2024. Validation of a 5-year prognostic model for Parkinson's disease. Mov. Disord. Clinical Practice. n\/a(n\/a).","DOI":"10.1002\/mdc3.14215"},{"issue":"10","key":"10.1016\/j.bbi.2025.04.028_b0315","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.028_b0320","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson's disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2025.04.028_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01081","article-title":"Immune cell activation in the cerebrospinal fluid of patients with Parkinson's disease","volume":"9","author":"Schr\u00f6der","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.028_b0330","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad060","article-title":"B lymphocyte responses in Parkinson's disease and their possible significance in disease progression","volume":"5","author":"Scott","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.bbi.2025.04.028_b0335","series-title":"Clinical Gerontology","first-page":"165","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter version","author":"Sheikh","year":"2014"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0340","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1751143720969587","article-title":"Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis","volume":"23","author":"Simadibrata","year":"2022","journal-title":"J. Intensive Care Soc."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7660","key":"10.1016\/j.bbi.2025.04.028_b0350","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"issue":"Pt 9","key":"10.1016\/j.bbi.2025.04.028_b0355","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awh219","article-title":"The regulatory role of natural killer cells in multiple sclerosis","volume":"127","author":"Takahashi","year":"2004","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.bbi.2025.04.028_b0360","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-021-00271-x","article-title":"Specific immune status in Parkinson's disease at different ages of onset","volume":"8","author":"Tian","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"15","key":"10.1016\/j.bbi.2025.04.028_b0370","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"issue":"23","key":"10.1016\/j.bbi.2025.04.028_b0375","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.3390\/ijms222313119","article-title":"Reduced immunosenescence of peripheral blood T cells in Parkinson\u2019s disease with CMV infection background","volume":"22","author":"Vavilova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.028_b0380","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.0000000000002437","article-title":"Development and external validation of a prognostic model in newly diagnosed Parkinson disease","volume":"86","author":"Velseboer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.04.028_b0385","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.028_b0390","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giy071","article-title":"Consistent decreased activity in the putamen in Parkinson's disease: a meta-analysis and an independent validation of resting-state fMRI","volume":"7","author":"Wang","year":"2018","journal-title":"GigaScience"},{"key":"10.1016\/j.bbi.2025.04.028_b0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbi.2020.01.018","article-title":"Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease","volume":"87","author":"Wijeyekoon","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.028_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.01.018","article-title":"Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease","author":"Wijeyekoon","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.028_b0405","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12974-018-1206-5","article-title":"Abnormalities of age-related T cell senescence in Parkinson's disease","volume":"15","author":"Williams-Gray","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bbi.2025.04.028_b0410","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mds.29363","article-title":"Brain and systemic inflammation in De Novo Parkinson's disease","volume":"38","author":"Yacoubian","year":"2023","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.028_b0415","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/jcbfm.2012.59","article-title":"Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies","volume":"32","author":"Yaqub","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbi.2025.04.028_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.933913","article-title":"Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis","volume":"9","author":"Ye","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbi.2025.04.028_b0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","article-title":"Plasma immune markers in an idiopathic REM sleep behavior disorder cohort","volume":"78","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.028_b0430","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00415-021-10877-z","article-title":"Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies","volume":"269","author":"Zhang","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2025.04.028_b0435","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Parkinsons Dis."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:36:49Z","timestamp":1763444209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":87,"alternative-id":["S0889159125001655"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.028","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral-central immune crosstalk in Parkinson\u2019s disease and its association with clinical severity","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}